Table 6 Fold change of gene expression in endothelial cells exposed to bevacizumab compared to endothelial cells exposed to ranibizumab
Gene symbol | Gene name | Bevacizumab/ranibizumab | Grade |
|---|---|---|---|
KDR | Kinase insert domain receptor | +5.547 | A |
NOS3 | Nitric oxide synthase 3 (endothelial cell) | +86.3228 | A |
NFATC2 | Nuclear factor of activated T-cells | -3.3708 | A |
PLA2G2E | Phospholipase A2, group IIE | -11.1207 | B |
PRKCG | Protein kinase C, gamma | -5.3751 | B |